Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015
Rheumatologists eagerly await trial data for Janus kinase inhibitors
Data
presented during ACR 2015 highlighted the potential impact the Janus kinase
inhibitors (JAKi) will bring to optimising treatment for rheumatoid arthritis
patients. Read more here http://goo.gl/djQAML